Clinical Validation of a Unani Pharmacopoeial formulation â?? Khamira Gawzaban Sada in Zuâ??f al-DimÄ?gh (Cerebro-asthenia)

Central Council for Research in Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Clinical presentation and/or history of any significant organic neurological diseases including space occupying lesions, stroke, head injury, seizure, and mental retardation
•2.Patients with impairment of speech, hearing and vision, which can impede the interview for MMSE and QOL assessment
•3.Known cases of hypothyroidism or hyperthyroidism
•4.Vitamin B12 deficiency
•5.Patients on Psychotropic Drugs
•6.Clinical presentation and/or history of a chronic disease that requires long-term treatment, e.g., DM, tuberculosis, HIV infection, syphilis, CVD, pulmonary disease, CKD, chronic liver disease, or any other serious and/or unstable medical condition that, in the opinion of the investigator, could expose the patients to undue risk of a significant adverse event or interfere with assessment of safety or efficacy during the course of the trial
•7.Pregnant and lactating women
•8.H/o Addiction (alcohol, drugs)
•9.H/o Hypersensitivity to the study drug or any of its ingredients

发起方